{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:24:49Z","timestamp":1789428289805,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-038-134"],"award-info":[{"award-number":["NSTC 112-2314-B-038-134"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2321-B-038-005"],"award-info":[{"award-number":["NSTC 112-2321-B-038-005"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2321-B-038-003"],"award-info":[{"award-number":["MOST 110-2321-B-038-003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2321-B-038-005"],"award-info":[{"award-number":["MOST 111-2321-B-038-005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU 111-AE2-I083"],"award-info":[{"award-number":["TMU 111-AE2-I083"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["A-0001574"],"award-info":[{"award-number":["A-0001574"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"crossref","award":["H-154-00-000019"],"award-info":[{"award-number":["H-154-00-000019"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Benzodiazepines (Diazepam) and related Z-drugs (Zolpidem), henceforth referred to as BZDRs, are widely used for clinical treatment of insomnia and anxiety disorders. BZDRs act on GABA type A receptors to inhibit neurotransmitters. We previously demonstrated that prolonged clinical use of BZDRs exacerbates the risk of breast cancer (BRCA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>By biomedical, health informatics platform analyses and in vivo studies, we explored clinical association between BZDR usage and BRCA development and advancement. Furthermore, by retrospective studies on patient clinical data and in vitro empirical analyses of the impact of BZDR on BRCA cells, and together with ingenuity pathway analysis (IPA) analyses, we validated the signaling pathways and identified potential intermolecular crosstalk involved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Clinical data showed that BRCA patients on long term treatment with BZDRs suffered increased mortality rate (p\u2009=\u20090.034). Studies on patient samples indicated that among 16 GABA receptors examined, GABRA3 (a pro-tumorigenic player) was significantly upregulated by BZDRs, which advanced BRCA disease. To support our clinical findings, we examined in vivo<jats:italic>,<\/jats:italic> the impact of BZDRs on BRCA advancement using MDA-MB231 cells to mediate metastasis in mice model. Our results show that BZDRs indeed promoted cancer advancement to the lungs and localized in the tibia. Using BRCA cell lines, we revealed the molecular-cellular effects of prolonged treatment with BZDRs in vitro. We showed significant metastasis indicated by increased cancer cell migration and invasion, which correlated well with our clinical observations. We discovered that BZDR-mediated GABRA3 stimulation was associated with downregulation of anti-tumorigenic extracellular matrix (ECM) molecules (S100B, COL6A6 and VIT) and upregulation of pro-tumorigenic FBN3 in BRCA cells. Notably, GABRA3-shRNA and GABRA3-CRISPR\/Cas9 disrupted the abovementioned dynamics dramatically and suppressed BRCA cell invasion induced by BZDRs. Bioinformatics analyses highlighted molecular pathways showing interplay between GABRA3 and ECMs, which presumably exacerbated BZDR-induced BRCA progression via immune modulators.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Long-term clinical use of BZDRs significantly increased the mortality rate of BRCA patients. We provide in vivo and in vitro evidence confirming that BZDRs promote BRCA advancement. We revealed that BZDR-mediated BRCA signaling pathways through GABRA3-ECMs, which promotes metastasis, probably through immune modulation and changes in the tumor microenvironment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s11658-025-00752-4","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T07:34:14Z","timestamp":1751182454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term treatment with benzodiazepines and related Z-drugs exacerbates breast cancer: clinical evidence and molecular mechanisms"],"prefix":"10.1186","volume":"30","author":[{"given":"Wei-Chung Vivian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeak Ling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Sheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phung-Anh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-2404","authenticated-orcid":false,"given":"Shu-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,29]]},"reference":[{"issue":"1","key":"752_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"752_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"19","key":"752_CR3","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1177\/15353702211032549","volume":"246","author":"D Bhattacharya","year":"2021","unstructured":"Bhattacharya D, Gawali VS, Kallay L, Toukam DK, Koehler A, Stambrook P, et al. Therapeutically leveraging GABA(A) receptors in cancer. Exp Biol Med. 2021;246(19):2128\u201335.","journal-title":"Exp Biol Med"},{"issue":"2","key":"752_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1152\/physrev.00044.2016","volume":"98","author":"N Prevarskaya","year":"2018","unstructured":"Prevarskaya N, Skryma R, Shuba Y. Ion channels in cancer: are cancer hallmarks oncochannelopathies? Physiol Rev. 2018;98(2):559\u2013621.","journal-title":"Physiol Rev"},{"key":"752_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fphys.2013.00185","volume":"4","author":"M Yang","year":"2013","unstructured":"Yang M, Brackenbury WJ. Membrane potential and cancer progression. Front Physiol. 2013;4:185.","journal-title":"Front Physiol"},{"issue":"4","key":"752_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00401-013-1205-7","volume":"127","author":"S Sengupta","year":"2014","unstructured":"Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, et al. \u03b15-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathol. 2014;127(4):593\u2013603.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"752_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.celrep.2016.03.013","volume":"15","author":"M Leonzino","year":"2016","unstructured":"Leonzino M, Busnelli M, Antonucci F, Verderio C, Mazzanti M, Chini B. The timing of the excitatory-to-inhibitory GABA switch is regulated by the oxytocin receptor via KCC2. Cell Rep. 2016;15(1):96\u2013103.","journal-title":"Cell Rep"},{"issue":"2","key":"752_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/cjn.2015.333","volume":"43","author":"M Avoli","year":"2016","unstructured":"Avoli M, Krnjevi\u0107 K. The long and winding road to gamma-amino-butyric acid as neurotransmitter. Can J Neurol Sci. 2016;43(2):219\u201326.","journal-title":"Can J Neurol Sci"},{"key":"752_CR9","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1038\/ncomms10715","volume":"7","author":"K Gumireddy","year":"2016","unstructured":"Gumireddy K, Li A, Kossenkov AV, Sakurai M, Yan J, Li Y, et al. The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nat Commun. 2016;7:10715.","journal-title":"Nat Commun"},{"issue":"11","key":"752_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103311","volume":"24","author":"B Wei","year":"2021","unstructured":"Wei B, Zhu Y, Yang P, Han Y, Wang S, Wang X, et al. GABA(B1e) promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12. iScience. 2021;24(11): 103311.","journal-title":"iScience."},{"issue":"1","key":"752_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1158\/1535-7163.MCT-05-0199","volume":"5","author":"HK Koblish","year":"2006","unstructured":"Koblish HK, Zhao S, Franks CF, Donatelli RR, Tominovich RM, LaFrance LV, et al. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo. Mol Cancer Ther. 2006;5(1):160\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"17","key":"752_CR12","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","volume":"14","author":"S Shangary","year":"2008","unstructured":"Shangary S, Wang S. Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res. 2008;14(17):5318\u201324.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"752_CR13","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.3390\/ijms150915741","volume":"15","author":"Z Yu","year":"2014","unstructured":"Yu Z, Zhuang C, Wu Y, Guo Z, Li J, Dong G, et al. Design, synthesis and biological evaluation of sulfamide and triazole benzodiazepines as novel p53-MDM2 inhibitors. Int J Mol Sci. 2014;15(9):15741\u201353.","journal-title":"Int J Mol Sci"},{"key":"752_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jbi.2017.08.008","volume":"74","author":"U Iqbal","year":"2017","unstructured":"Iqbal U, Chang T-H, Nguyen P-A, Syed-Abdul S, Yang H-C, Huang C-W, et al. Benzodiazepines use and breast cancer risk: a population-based study and gene expression profiling evidence. J Biomed Inform. 2017;74:85\u201391.","journal-title":"J Biomed Inform"},{"issue":"3","key":"752_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ijc.30443","volume":"140","author":"HB Kim","year":"2017","unstructured":"Kim HB, Myung SK, Park YC, Park B. Use of benzodiazepine and risk of cancer: a meta-analysis of observational studies. Int J Cancer. 2017;140(3):513\u201325.","journal-title":"Int J Cancer"},{"issue":"10","key":"752_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/medicina56100513","volume":"56","author":"TR Peng","year":"2020","unstructured":"Peng TR, Yang LJ, Wu TW, Chao YC. Hypnotics and risk of cancer: a meta-analysis of observational studies. Medicina. 2020;56(10):513.","journal-title":"Medicina"},{"issue":"60","key":"752_CR17","doi-asserted-by":"publisher","first-page":"102381","DOI":"10.18632\/oncotarget.22057","volume":"8","author":"T Zhang","year":"2017","unstructured":"Zhang T, Yang X, Zhou J, Liu P, Wang H, Li A, et al. Benzodiazepine drug use and cancer risk: a dose-response meta analysis of prospective cohort studies. Oncotarget. 2017;8(60):102381\u201391.","journal-title":"Oncotarget"},{"issue":"4","key":"752_CR18","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.4088\/JCP.11m07333","volume":"73","author":"CH Kao","year":"2012","unstructured":"Kao CH, Sun LM, Su KP, Chang SN, Sung FC, Muo CH, et al. Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. J Clin Psychiatry. 2012;73(4):e555\u201360.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"752_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000483","volume":"94","author":"U Iqbal","year":"2015","unstructured":"Iqbal U, Nguyen PA, Syed-Abdul S, Yang HC, Huang CW, Jian WS, et al. Is long-term use of benzodiazepine a risk for cancer? Medicine. 2015;94(6): e483.","journal-title":"Medicine"},{"issue":"1","key":"752_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1124\/mol.110.069542","volume":"80","author":"EV Morlock","year":"2011","unstructured":"Morlock EV, Czajkowski C. Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding. Mol Pharmacol. 2011;80(1):14\u201322.","journal-title":"Mol Pharmacol"},{"key":"752_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1479-5876-11-102","volume":"11","author":"X Zhang","year":"2013","unstructured":"Zhang X, Zhang R, Zheng Y, Shen J, Xiao D, Li J, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med. 2013;11:102.","journal-title":"J Transl Med"},{"issue":"23","key":"752_CR22","first-page":"8090","volume":"63","author":"H Azuma","year":"2003","unstructured":"Azuma H, Inamoto T, Sakamoto T, Kiyama S, Ubai T, Shinohara Y, et al. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Can Res. 2003;63(23):8090\u20136.","journal-title":"Can Res"},{"issue":"13_Supplement","key":"752_CR23","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/1538-7445.AM2018-2162","volume":"78","author":"R Li","year":"2018","unstructured":"Li R, Huang Y, Liu H, Dilger JP, Lin J. Comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis. Cancer Res. 2018;78(13_Supplement):2162.","journal-title":"Cancer Res"},{"issue":"2","key":"752_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer. 2022;3(2):232\u201350.","journal-title":"Nat Cancer"},{"key":"752_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/bonekey.2016.31","volume":"5","author":"LE Wright","year":"2016","unstructured":"Wright LE, Ottewell PD, Rucci N, Peyruchaud O, Pagnotti GM, Chiechi A, et al. Murine models of breast cancer bone metastasis. Bonekey Rep. 2016;5:804.","journal-title":"Bonekey Rep"},{"issue":"7","key":"752_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/onc.2008.454","volume":"28","author":"AA Mourskaia","year":"2009","unstructured":"Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O\u2019Connor-McCourt MD, et al. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Oncogene. 2009;28(7):1005\u201315.","journal-title":"Oncogene"},{"issue":"3","key":"752_CR27","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/bcr3183","volume":"14","author":"KE Fathers","year":"2012","unstructured":"Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A, et al. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Res. 2012;14(3):R74.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"752_CR28","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/cancers12082210","volume":"12","author":"SC Chang","year":"2020","unstructured":"Chang SC, Hsu W, Su EC, Hung CS, Ding JL. Human FBXL8 is a novel E3 ligase which promotes BRCA metastasis by stimulating pro-tumorigenic cytokines and inhibiting tumor suppressors. Cancers. 2020;12(8):2210.","journal-title":"Cancers"},{"issue":"23","key":"752_CR29","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.3390\/cancers14235727","volume":"14","author":"L Pang","year":"2022","unstructured":"Pang L, Gan C, Xu J, Jia Y, Chai J, Huang R, et al. Bone metastasis of breast cancer: molecular mechanisms and therapeutic strategies. Cancers. 2022;14(23):5727.","journal-title":"Cancers"},{"issue":"4","key":"752_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ilar.43.4.244","volume":"43","author":"MF Festing","year":"2002","unstructured":"Festing MF, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. Ilar j. 2002;43(4):244\u201358.","journal-title":"Ilar j"},{"issue":"10","key":"752_CR31","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.5664\/jcsm.7370","volume":"14","author":"JW Choi","year":"2018","unstructured":"Choi JW, Lee J, Jung SJ, Shin A, Lee YJ. Use of sedative-hypnotics and mortality: a population-based retrospective cohort study. J Clin Sleep Med. 2018;14(10):1669\u201377.","journal-title":"J Clin Sleep Med"},{"issue":"17","key":"752_CR32","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1523\/JNEUROSCI.5663-11.2012","volume":"32","author":"MC Gielen","year":"2012","unstructured":"Gielen MC, Lumb MJ, Smart TG. Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding. J Neurosci. 2012;32(17):5707\u201315.","journal-title":"J Neurosci"},{"issue":"20","key":"752_CR33","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1158\/0008-5472.CAN-07-2099","volume":"67","author":"A Takehara","year":"2007","unstructured":"Takehara A, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, et al. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Can Res. 2007;67(20):9704\u201312.","journal-title":"Can Res"},{"issue":"9","key":"752_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41388-022-02584-4","volume":"42","author":"P Jayachandran","year":"2023","unstructured":"Jayachandran P, Battaglin F, Strelez C, Lenz A, Algaze S, Soni S, et al. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions. Oncogene. 2023;42(9):627\u201337.","journal-title":"Oncogene"},{"key":"752_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2024.102042","volume":"37","author":"H Liu","year":"2024","unstructured":"Liu H, Guo Z, Wang P. Genetic expression in cancer research: challenges and complexity. Gene Rep. 2024;37: 102042.","journal-title":"Gene Rep"},{"issue":"1","key":"752_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Li Y, Karsidag M, Tu T, Wang P. Technical and biological biases in bulk transcriptomic data mining for cancer research. J Cancer. 2025;16(1):34\u201343.","journal-title":"J Cancer"},{"issue":"1","key":"752_CR37","doi-asserted-by":"publisher","first-page":"14934","DOI":"10.1038\/s41598-019-51453-w","volume":"9","author":"VB Wali","year":"2019","unstructured":"Wali VB, Patwardhan GA, Pelekanou V, Karn T, Cao J, Ocana A, et al. Identification and validation of a novel biologics target in triple negative breast cancer. Sci Rep. 2019;9(1):14934.","journal-title":"Sci Rep"},{"issue":"22","key":"752_CR38","doi-asserted-by":"publisher","first-page":"32341","DOI":"10.18632\/oncotarget.8700","volume":"7","author":"L Liu","year":"2016","unstructured":"Liu L, Yang C, Shen J, Huang L, Lin W, Tang H, et al. GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases. Oncotarget. 2016;7(22):32341\u201350.","journal-title":"Oncotarget"},{"key":"752_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2019","unstructured":"Henke E, Nandigama R, Erg\u00fcn S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci. 2019;6:160.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"752_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"752_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231594","volume":"15","author":"VK Yadav","year":"2020","unstructured":"Yadav VK, Lee TY, Hsu JB, Huang HD, Yang WV, Chang TH. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression. PLoS ONE. 2020;15(4): e0231594.","journal-title":"PLoS ONE"},{"issue":"2","key":"752_CR42","first-page":"433","volume":"52","author":"MC Yen","year":"2018","unstructured":"Yen MC, Huang YC, Kan JY, Kuo PL, Hou MF, Hsu YL. S100B expression in breast cancer as a predictive marker for cancer metastasis. Int J Oncol. 2018;52(2):433\u201340.","journal-title":"Int J Oncol"},{"key":"752_CR43","doi-asserted-by":"crossref","unstructured":"Mamoor S. Differential expression of vitrin in cancers of the breast. 2021.","DOI":"10.31219\/osf.io\/xnp7j"},{"issue":"8","key":"752_CR44","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.21873\/anticanres.12764","volume":"38","author":"MH Yeh","year":"2018","unstructured":"Yeh MH, Tzeng YJ, Fu TY, You JJ, Chang HT, Ger LP, et al. Extracellular matrix-receptor interaction signaling genes associated with inferior breast cancer survival. Anticancer Res. 2018;38(8):4593\u2013605.","journal-title":"Anticancer Res"},{"key":"752_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2020.100304","volume":"24","author":"S Liu","year":"2020","unstructured":"Liu S, Song A, Zhou X, Huo Z, Yao S, Yang B, et al. ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone. J Bone Oncol. 2020;24: 100304.","journal-title":"J Bone Oncol"},{"key":"752_CR46","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.2147\/OTT.S248085","volume":"13","author":"K Zhang","year":"2020","unstructured":"Zhang K, Tian R, Wang G, Zhang J, Ma H, Hu X, et al. ADAMTS8 inhibits cell proliferation and invasion, and induces apoptosis in breast cancer. Onco Targets Ther. 2020;13:8373\u201382.","journal-title":"Onco Targets Ther"},{"issue":"10","key":"752_CR47","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.21037\/tcr-21-2002","volume":"10","author":"H Qiao","year":"2021","unstructured":"Qiao H, Feng Y, Tang H. COL6A6 inhibits the proliferation and metastasis of non-small cell lung cancer through the JAK signalling pathway. Transl Cancer Res. 2021;10(10):4514\u201322.","journal-title":"Transl Cancer Res"},{"issue":"20","key":"752_CR48","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.18632\/aging.102300","volume":"11","author":"R Long","year":"2019","unstructured":"Long R, Liu Z, Li J, Yu H. COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway. Aging. 2019;11(20):8845\u201359.","journal-title":"Aging"},{"key":"752_CR49","doi-asserted-by":"crossref","unstructured":"Mamoor S. Differential expression of pseudouridylate synthase 1 in cancers of the breast. 2022.","DOI":"10.31219\/osf.io\/yjsx6"},{"issue":"1","key":"752_CR50","doi-asserted-by":"publisher","first-page":"2413719","DOI":"10.1080\/2162402X.2024.2413719","volume":"13","author":"L Mont\u00e9gut","year":"2024","unstructured":"Mont\u00e9gut L, Derosa L, Messaoudene M, Chen H, Lambertucci F, Routy B, et al. Benzodiazepines compromise the outcome of cancer immunotherapy. OncoImmunology. 2024;13(1):2413719.","journal-title":"OncoImmunology"},{"issue":"21","key":"752_CR51","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.18632\/oncotarget.2521","volume":"5","author":"C Zhuang","year":"2014","unstructured":"Zhuang C, Sheng C, Shin WS, Wu Y, Li J, Yao J, et al. A novel drug discovery strategy: mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-\u03baB pathways. Oncotarget. 2014;5(21):10830\u20139.","journal-title":"Oncotarget"},{"issue":"3","key":"752_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0161-4630(79)90103-4","volume":"3","author":"RA Karmali","year":"1979","unstructured":"Karmali RA, Volkman A, Muse P, Louis TM. The influence of diazepam administration in rats bearing the R3230AC mammary carcinoma. Prostaglandins Med. 1979;3(3):193\u20138.","journal-title":"Prostaglandins Med"},{"issue":"1","key":"752_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0306-9877(81)90027-X","volume":"7","author":"DF Horrobin","year":"1981","unstructured":"Horrobin DF, Trosko JE. The possible effect of diazepam on cancer development and growth. Med Hypotheses. 1981;7(1):115\u201325.","journal-title":"Med Hypotheses"},{"issue":"1","key":"752_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000330814","volume":"81","author":"R Vaidya","year":"2011","unstructured":"Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011;81(1):9\u201311.","journal-title":"Oncology"},{"issue":"1","key":"752_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/syn.890010113","volume":"1","author":"DA Mathers","year":"1987","unstructured":"Mathers DA. The GABAA receptor: new insights from single-channel recording. Synapse. 1987;1(1):96\u2013101.","journal-title":"Synapse"},{"issue":"2","key":"752_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mehy.2009.09.003","volume":"74","author":"MT Bianchi","year":"2010","unstructured":"Bianchi MT. Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications. Med Hypotheses. 2010;74(2):297\u2013300.","journal-title":"Med Hypotheses"},{"issue":"35","key":"752_CR57","doi-asserted-by":"publisher","first-page":"24102","DOI":"10.1074\/jbc.M114.593582","volume":"289","author":"GM Sizemore","year":"2014","unstructured":"Sizemore GM, Sizemore ST, Seachrist DD, Keri RA. GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1\/2 (ERK1\/2). J Biol Chem. 2014;289(35):24102\u201313.","journal-title":"J Biol Chem"},{"key":"752_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2016.11.003","volume":"108","author":"SC Chang","year":"2016","unstructured":"Chang SC, Yang WV. Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol. 2016;108:146\u201353.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"752_CR59","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120.","journal-title":"Nat Commun"},{"issue":"18","key":"752_CR60","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-23-0547","volume":"29","author":"AC Cornwell","year":"2023","unstructured":"Cornwell AC, Tisdale AA, Venkat S, Maraszek KE, Alahmari AA, George A, et al. Lorazepam stimulates IL6 production and is associated with poor survival outcomes in pancreatic cancer. Clin Cancer Res. 2023;29(18):3793\u2013812.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"752_CR61","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1080\/08820139.2023.2249025","volume":"52","author":"A Chauhan","year":"2023","unstructured":"Chauhan A, Agarwal S, Masih M, Gautam PK. The multifunction role of tumor-associated mesenchymal stem cells and their interaction with immune cells in breast cancer. Immunol Invest. 2023;52(7):856\u201378.","journal-title":"Immunol Invest"},{"issue":"1","key":"752_CR62","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1038\/s41467-019-12807-0","volume":"10","author":"R Eyre","year":"2019","unstructured":"Eyre R, Alf\u00e9rez DG, Santiago-G\u00f3mez A, Spence K, McConnell JC, Hart C, et al. Microenvironmental IL1\u03b2 promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Nat Commun. 2019;10(1):5016.","journal-title":"Nat Commun"},{"issue":"3","key":"752_CR63","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/path.6395","volume":"265","author":"X Lu","year":"2025","unstructured":"Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, et al. Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer. J Pathol. 2025;265(3):385\u201399.","journal-title":"J Pathol"},{"issue":"1","key":"752_CR64","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12943-024-02150-4","volume":"23","author":"J-H Kang","year":"2024","unstructured":"Kang J-H, Uddin N, Kim S, Zhao Y, Yoo K-C, Kim M-J, et al. Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR. Mol Cancer. 2024;23(1):230.","journal-title":"Mol Cancer"},{"issue":"4","key":"752_CR65","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/cas.15293","volume":"113","author":"H Hayasaka","year":"2022","unstructured":"Hayasaka H, Yoshida J, Kuroda Y, Nishiguchi A, Matsusaki M, Kishimoto K, et al. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels. Cancer Sci. 2022;113(4):1338\u201351.","journal-title":"Cancer Sci"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00752-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T20:01:35Z","timestamp":1751227295000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00752-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00752-4","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,29]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent, and the collection of human primary samples was approved by the Taipei Medical University-Joint Institutional Review Board, Taipei, Taiwan, following the Declaration of Helsinki (Approval number: N202201089, Dated: 24 February 2022). All in vivo experiments were performed in accordance to the \u201cGuide for the Care and Use of Laboratory Animals\u201d (NIH publication 86-23, revised 1985) and was approved by the Committee for Ethics of Animal Experiments of TRINEO BIOTECHNOLOGY CO., LTD. (Approval number: IACUC-2024-SH-018, Dated: 12 August 2024) [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors concur with the submission and confirm acceptance of the charge policy provided by Cellular & Molecular Biology Letters if this manuscript is accepted for publication. This manuscript is an original research article and no part of it has been published or is being considered for publication elsewhere. An earlier version of study has been posted on a non-commercial preprint server prior to submission (; ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no financial or commercial conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}